← Back to Search

ultrasound for Breast Cancer

N/A
Waitlist Available
Led By Kristie Osteen, MD
Research Sponsored by Ochsner Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours
Awards & highlights

Study Summary

The purpose of this study is to compare ultrasound and predetermined distance techniques for finding the paravertebral space to inject the local anesthetic (numbing medicine) when you are given anesthesia for surgery. The paravertebral space is located on either side of the spinal cord and contains the nerves that provide sensation to the chest wall. The predetermined distance technique is a series of measurements taken to determine the location of the paravertebral space where the local anesthetic is injected. The ultrasound technique uses direct visualization of the local anesthetic being placed in the paravertebral space. This type of anesthesia has many benefits including decreasing your pain after breast surgery.

Eligible Conditions
  • Breast Cancer
  • Mastectomy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Visual analog scores(VAS)for pain and perioperative opioid requirements
Secondary outcome measures
time, incidence of adverse events and patient satisfaction

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ultrasoundExperimental Treatment1 Intervention
Ultrasound guidance will be used for paravertebral space localization when performing paravertebral blocks on females 25-85 having unilateral mastectomy.
Group II: predetermined distanceActive Control1 Intervention
The predetermined distance technique will be used for paravertebral space localization when performing paravertebral blocks on females 25-85 having unilateral mastectomy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ultrasound
2003
Completed Phase 3
~49260

Find a Location

Who is running the clinical trial?

Ochsner Health SystemLead Sponsor
93 Previous Clinical Trials
184,601 Total Patients Enrolled
Kristie Osteen, MDPrincipal InvestigatorOchsner Health System

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025